{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T01:40:31Z","timestamp":1781142031450,"version":"3.54.1"},"reference-count":15,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,8]],"date-time":"2025-07-08T00:00:00Z","timestamp":1751932800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["jaadcasereports.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JAAD Case Reports"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.jdcr.2025.05.048","type":"journal-article","created":{"date-parts":[[2025,7,15]],"date-time":"2025-07-15T23:53:47Z","timestamp":1752623627000},"page":"46-49","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["A case series of dupilumab for vitiligo and alopecia areata in the setting of atopic dermatitis"],"prefix":"10.1016","volume":"64","author":[{"given":"Dev","family":"Patel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9117-0109","authenticated-orcid":false,"given":"Ben","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Omar","family":"Alani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4274-7597","authenticated-orcid":false,"given":"Nanette","family":"Silverberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10356","key":"10.1016\/j.jdcr.2025.05.048_bib1","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1016\/S0140-6736(22)01539-2","article-title":"Dupilumab in children aged 6 months to younger than 6 years with uncontrolled atopic dermatitis: a randomised, double-blind, placebo-controlled, phase 3 trial","volume":"400","author":"Paller","year":"2022","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.jdcr.2025.05.048_bib2","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1001\/jamadermatol.2021.4724","article-title":"Prevalence of vitiligo among adults in the United States","volume":"158","author":"Gandhi","year":"2022","journal-title":"JAMA Dermatol"},{"issue":"2","key":"10.1016\/j.jdcr.2025.05.048_bib3","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1159\/000528180","article-title":"Prevalence of vitiligo among children and adolescents in the United States","volume":"239","author":"Patel","year":"2023","journal-title":"Dermatology"},{"key":"10.1016\/j.jdcr.2025.05.048_bib4","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1007\/s13671-014-0098-6","article-title":"The epidemiology of vitiligo","volume":"4","author":"Silverberg","year":"2015","journal-title":"Curr Derm Rep"},{"issue":"1","key":"10.1016\/j.jdcr.2025.05.048_bib5","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.abd.2021.02.014","article-title":"Vitiligo and atopic dermatitis in young girls: may Koebner phenomenon play a role?","volume":"98","author":"Ravaioli","year":"2023","journal-title":"An Bras Dermatol"},{"issue":"8","key":"10.1016\/j.jdcr.2025.05.048_bib6","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1001\/jamadermatol.2013.4228","article-title":"Association between vitiligo and atopic disorders: a pilot study","volume":"149","author":"Silverberg","year":"2013","journal-title":"JAMA Dermatol"},{"issue":"4","key":"10.1016\/j.jdcr.2025.05.048_bib7","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1001\/jamadermatol.2024.0021","article-title":"Expert recommendations on use of topical therapeutics for vitiligo in pediatric, adolescent, and young adult patients","volume":"160","author":"Renert-Yuval","year":"2024","journal-title":"JAMA Dermatol"},{"issue":"1","key":"10.1016\/j.jdcr.2025.05.048_bib8","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2015-4126","article-title":"A practical approach to the diagnosis and treatment of vitiligo in children","volume":"138","author":"Ezzedine","year":"2016","journal-title":"Pediatrics"},{"issue":"6","key":"10.1016\/j.jdcr.2025.05.048_bib9","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1016\/j.jaad.2022.01.009","article-title":"American Academy of Dermatology Guidelines: awareness of comorbidities associated with atopic dermatitis in adults","volume":"86","author":"Davis","year":"2022","journal-title":"J Am Acad Dermatol"},{"issue":"17","key":"10.1016\/j.jdcr.2025.05.048_bib10","doi-asserted-by":"crossref","first-page":"5225","DOI":"10.3390\/jcm13175225","article-title":"Vitiligo: from pathogenesis to treatment","volume":"13","author":"Speeckaert","year":"2024","journal-title":"J Clin Med"},{"issue":"3","key":"10.1016\/j.jdcr.2025.05.048_bib11","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1111\/all.15071","article-title":"Phase 2a randomized clinical trial of dupilumab (anti-IL-4R\u03b1) for alopecia areata patients","volume":"77","author":"Guttman-Yassky","year":"2022","journal-title":"Allergy"},{"issue":"5","key":"10.1016\/j.jdcr.2025.05.048_bib12","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1016\/j.jaci.2015.06.032","article-title":"Alopecia areata profiling shows TH1, TH2, and IL-23 cytokine activation without parallel TH17\/TH22 skewing","volume":"136","author":"Su\u00e1rez-Fari\u00f1as","year":"2015","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jdcr.2025.05.048_bib13","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.jdcr.2023.09.006","article-title":"Incidental improvement of programmed cell death-1 receptor inhibitor-induced vitiligo after initiation of dupilumab therapy for refractory pruritus","volume":"42","author":"Robinson","year":"2023","journal-title":"JAAD Case Rep"},{"key":"10.1016\/j.jdcr.2025.05.048_bib14","article-title":"A Mendelian randomization study on the causal effects of circulating cytokines on the risk of vitiligo","volume":"11","author":"Liu","year":"2024","journal-title":"Front Med (Lausanne)"},{"key":"10.1016\/j.jdcr.2025.05.048_bib15","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.jdcr.2023.03.025","article-title":"Vitiligo during dupilumab therapy","volume":"36","author":"Picone","year":"2023","journal-title":"JAAD Case Rep"}],"container-title":["JAAD Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352512625003182?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352512625003182?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,12]],"date-time":"2025-12-12T00:24:04Z","timestamp":1765499044000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352512625003182"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":15,"alternative-id":["S2352512625003182"],"URL":"https:\/\/doi.org\/10.1016\/j.jdcr.2025.05.048","relation":{},"ISSN":["2352-5126"],"issn-type":[{"value":"2352-5126","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A case series of dupilumab for vitiligo and alopecia areata in the setting of atopic dermatitis","name":"articletitle","label":"Article Title"},{"value":"JAAD Case Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jdcr.2025.05.048","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Inc. on behalf of the American Academy of Dermatology, Inc.","name":"copyright","label":"Copyright"}]}}